Cancer in Southeast Asia: A comparative analysis of 2022 incidence and mortality data.

Authors

Edward Dee

Edward Christopher Christopher Dee

Memorial Sloan Kettering Cancer Center, New York, NY

Edward Christopher Christopher Dee , Michelle Ann Eala , Mathieu Laversanne , Ophira Ginsburg , Scarlett L. Gomez , Erin Jay Garbes Feliciano , Kenrick Ng , Tomohiro Matsuda , Suleeporn Sangrajrang , Nirmala Bhoo Pathy , Evlianeat Suzanna , Tung Duc Bui , Wen-Qiang Wei , Young-Joo Won , Ling Li Foo , Annie Ling , Les Mery , Isabelle Soerjomataram , Freddie Bray

Organizations

Memorial Sloan Kettering Cancer Center, New York, NY, University of the Philippines College of Medicine, Manila, Philippines, International Agency for Research on Cancer, Lyon, France, National Cancer Institute, Bethesda, MD, Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, Department of Medicine, NYC Health + Hospitals/Elmhurst, Icahn School of Medicine at Mount Sinai, Queens, NY, Barts Health NHS Trust, London, United Kingdom, Center for Cancer Registries, Center for Cancer Control and Information Services, National Cancer Center, Tokyo, Japan, National Cancer Institute of Thailand, Ratchathewi, Thailand, Universiti Malaya, Kuala Lumpur, Malaysia, Dharmais National Cancer Center Indonesia, Jakarta, Indonesia, Ho Chi Minh City Oncological Hospital, Ho Chi Minh, Viet Nam, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China, Yonsei University, Wonju, Gangwon-Do, South Korea, Health Promotion Board, Singapore, Singapore

Research Funding

National Cancer Institute/U.S. National Institutes of Health

Background: Southeast Asia (SEA), home to over 680 million people representing almost 9% of the global population, is amongst the most diverse and fastest-growing regions in the world. This study evaluates cancer incidence and mortality in Association of Southeast Asian Nations (ASEAN) countries with the goal of informing future research, health services, and cancer policy in the region. Methods: The number of new cases of and deaths from the leading cancers in the ASEAN region, colorectum including anus (ICD-10 C18-C21), liver including intrahepatic bile ducts (C22), lung including trachea and bronchus (C33-34), female breast (C50), cervix uteri (C53) and prostate (C61), were extracted from the International Agency for Research on Cancer GLOBOCAN 2022database for the 10 ASEAN countries by sex and age groups. Age-standardized incidence and mortality rates (ASIR and ASMR) per 100,000 person-years are presented. Results: In 2022, breast cancer was the most common cancer among women in all ten ASEAN countries (ASIR: Singapore 72.6, Philippines 60.3, Brunei 50.2, Malaysia 46.1, Indonesia 41.8, Vietnam 38.0, Thailand 37.4, Laos 31.6, Cambodia 25.1, Myanmar 23.4). Breast cancer was also the most common cause of cancer mortality among women in five ASEAN countries (ASMR: Philippines 21.5, Malaysia 19.3, Singapore 17.8, Vietnam 14.7, Indonesia 14.4). In Thailand for which time trends are available, ASIR has risen from 19 per 100,000 in 2000 to 37.4 per 100,000 in 2022. Lung cancer was the most common cancer among men in the Philippines (ASIR 37.7), Malaysia (ASIR 23.3), Myanmar (ASIR 21.6), and Indonesia (ASIR 21.3). Lung cancer is also the leading cause of cancer death among men in the Philippines (ASMR 33.6), Singapore (ASMR 31.9), Brunei Darussalam (ASMR 23.8), Malaysia (ASMR 20.4), Myanmar (ASMR 19.9), and Indonesia (ASMR 19.0). Lung cancer is also the leading cause of cancer death among women in Brunei Darussalam (ASMR 18.4). Liver cancer contributes the greatest incidence and mortality among men in Cambodia (ASIR 39.4, ASMR 37.2), Laos (ASIR 36.5, ASMR 36.4), Vietnam (ASIR 34.9, ASMR 33.3), and Thailand (ASIR 34.4, ASMR 33.4). Liver cancer was also the leading cause of cancer death among women in Laos (ASMR 13.5), Cambodia (ASMR 13.3), and Thailand (ASMR 12.1). Cervical cancer is the leading cause of cancer death amongst women in Myanmar (ASMR 13.4). Colorectum cancer is the most common cancer in men in Singapore (ASIR 39.4) and Brunei Darussalam (ASIR 37.7). Conclusions: In 2022, cancer incidence and mortality in SEA were driven primarily by breast cancer among women and lung cancer among men. Liver cancer drives incidence and mortality in Cambodia, Laos, Thailand, and Vietnam. Cervical cancer and colorectal cancer are also significant contributors to incidence and mortality in SEA. Regional and global collaboration is needed to improve cancer prevention, access to diagnosis and care, and research in Southeast Asia.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Prevention, Risk Reduction, and Genetics

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Etiology/Epidemiology

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr 10564)

DOI

10.1200/JCO.2024.42.16_suppl.10564

Abstract #

10564

Poster Bd #

91

Abstract Disclosures

Similar Abstracts

First Author: Justin Michael Barnes

First Author: Justin Michael Barnes

First Author: Vasanthan Muthusamy Kumarasamy

Abstract

2024 ASCO Annual Meeting

The effect of advances in management of uterine-serous-carcinoma on population mortality.

First Author: Aifen Wang